Acro Biomedical (ACBM) Cash from Financing Activities (2017 - 2025)
Acro Biomedical (ACBM) recorded quarterly Cash from Financing Activities of $25152.0 in Q4 2025, down 57.16% quarter-over-quarter from $58707.0 in Q3 2025, and up 144.43% on a YoY basis from $10290.0 in Q4 2024.
Acro Biomedical (ACBM) Cash from Financing Activities (2017 - 2025) Analysis & Trends
Acro Biomedical's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $25152.0 for Q4 2025.
- In Q4 2025, Cash from Financing Activities rose 144.43% year-over-year to $25152.0; the TTM figure through Dec 2025 stood at $199924.0 (up 443.39% YoY), while the FY2025 annual figure was $199924.0, up 443.39% from the prior year.
- Cash from Financing Activities was $25152.0 for Q4 2025 at Acro Biomedical, down from $58707.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $93759.0 in Q2 2025 to a low of -$241635.0 in Q2 2021.
- Historically, Cash from Financing Activities has averaged $4128.0 across 5 years, with a median of $6607.0 in 2024.
- The sharpest annual moves came in 2021 and 2024: Cash from Financing Activities sank 492.42% in 2021, then soared 36811.11% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $1091.0 in 2021, then sank by 78.74% to $232.0 in 2022, then jumped by 4088.79% to $9718.0 in 2023, then increased by 5.89% to $10290.0 in 2024, then jumped by 144.43% to $25152.0 in 2025.
- The last three Cash from Financing Activities figures came in at $25152.0 (Q4 2025), $58707.0 (Q3 2025), and $93759.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | -43,625.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | -250,000.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 500,000.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | -13,092.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | -17.38 Mn |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 25,152.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25,152.00 |
| Dec 31, 2025 | 25,152.00 |
| Sep 30, 2025 | 58,707.00 |
| Sep 30, 2025 | 58,707.00 |
| Jun 30, 2025 | 93,759.00 |
| Jun 30, 2025 | 93,759.00 |
| Mar 31, 2025 | 22,306.00 |
| Mar 31, 2025 | 22,306.00 |
| Dec 31, 2024 | 10,290.00 |
| Dec 31, 2024 | 10,290.00 |
| Sep 30, 2024 | 6,110.00 |
| Sep 30, 2024 | 6,110.00 |
| Jun 30, 2024 | 7,104.00 |
| Jun 30, 2024 | 7,104.00 |
| Mar 31, 2024 | 13,288.00 |
| Mar 31, 2024 | 13,288.00 |
| Dec 31, 2023 | 9,718.00 |
| Dec 31, 2023 | 9,718.00 |
| Sep 30, 2023 | 108.00 |
| Sep 30, 2023 | 108.00 |